Role of Exercise in Breast Cancer Patient Undergoing Treatment
- Conditions
- Breast Cancer Patients
- Interventions
- Other: Yoga Exercises
- Registration Number
- NCT05009849
- Lead Sponsor
- Tata Memorial Centre
- Brief Summary
Randomized controlled trial to evaluate the impact of yoga on QOL is also powered to evaluate the impact of yoga on survival. Study involves various phases of yoga(divided in three phases: Phase I/II/III) during treatment and survivorship, with a comparative analysis of different time points and the response to yoga, which will help integrating yoga as a complementary modality. Also, this study will help identify the long term and short term effects of this therapy in breast cancer patients and survivors.
One of the main differences between yoga and other forms of physical activity is that yoga exercises oppose violent muscle movement and is designed to counteract fatigue through relaxation and breathing. 6 monthly Follow Up will be for 5 years followed by yearly follow up.
- Detailed Description
Women with breast cancer are constantly exploring measures in addition to ongoing conventional therapy to relieve disease related symptoms, minimize side effects associated with conventional treatment, reduce their risk of recurrence and enhance their prospects for survival. Breast cancer survival rates have considerably improved over the years with the advent of new therapeutic measures and early detection. However its treatment sequelae are associated with significant changes in quality of life (QOL) and well being. Fatigue is one of the most prevalent QOL concerns, affecting 30% to 70% of breast cancer survivors.
Yoga is based on the practice of physical postures, breathing techniques and meditation. Philosophically, it aims at increasing the body's ability to master the mind with the goal of spiritual awareness and connection. A randomized trial of yoga in women with breast cancer undergoing radiation therapy demonstrated an improvement in impact of events scale at 3 months suggesting that the more intrusive thoughts at 1 month the greater the finding of meaning in cancer by 3 months.
* This is the first randomized controlled trial of this magnitude (850 women), which in addition to testing the impact of yoga on QOL is also powered to evaluate the impact of yoga on survival
* This is a longitudinal study measuring various phases of yoga during treatment and survivorship, with a comparative analysis of different time points and the response to yoga , which will help integrating yoga as a complementary modality
* Also, this study will help identify the long term and short term effects of this therapy in breast cancer patients and survivors
* The exercises are carefully designed keeping the phase of treatment or recovery of the breast cancer patient/survivor in focus.
* Chronic ailments have also been kept in mind (eg: which impede mobility or flexibility ie: spondylosis)
* One of the main differences between yoga and other forms of physical activity is that yoga exercises oppose violent muscle movement and is designed to counteract fatigue through relaxation and breathing.
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- Female
- Target Recruitment
- 850
- Women with unilateral breast cancer
- Age 18-65 years
- Metastatic breast cancer
- Pregnant Women
- Women with physical limitations to perform exercises
- Previous history of cancer
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Exercise II Yoga Exercises Objective assessment at baseline, 14 days, 6-9, 12-15, 18-21, 36-39 and 54-57 months Exercise I Yoga Exercises Yogic and Routine Exercises (referred to as exercise I) Phase I: 1-7 days (Minimum attendance 4 days), Phase II: 8 - 14 days (Minimum attendance 4 days), Phase III: at 6-9 months or 12-15 months 1 year up gradation of exercises at 6-9 month or 12-15 months 1 year (Depending upon compliance to phase II exercises) Objective assessment at baseline, 14 days, 6-9, 12-15, 18-21, 36-39 and 54-57 months Exercise evaluation will be done at 6-9, 12-15, 30-33, 48-51 and 66-69 months
- Primary Outcome Measures
Name Time Method Disease-free survival From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 60 months. To assess the effect of yoga on disease free survival in women breast cancer.
- Secondary Outcome Measures
Name Time Method Assess the impact of Yoga on inflammatory cytokines and cell free chromatin From randomization to 12 months The impact of yoga on inflammatory markers will be assessed by using serum samples to check the concentration of IL2, TNF alpha, IL6, IL8, IL10 and C reactive protein by using ELISA technique.
Pain assessment from randomization to 60 months To assess the effect of yoga using Pain Assessment chart questionnaire, having score scale from scale 0 to 10 wherein 0 represent "No Pain" and 10 represent "Worst Possible Pain"
Quality of life assessment from randomization to 60 months To assess the effect of yoga using Quality of life questionnaire (QLQ-30, BR-23, Spirituality \& BFI having score scale from 1-4, wherein 1 represents 'Not at All' and 4 'very much'
Improvements in Lung Function The FEV1/ FVC ratio and the value will be checked, if the value is within 80% to 120%, it will be considered as normal (95 percent confidence interval). From randomization until 12 months. To assess the effect of yoga in improving the Lung Function by evaluating Pulmonary Function Teast (PFT) readings.
Improvements in Overall survival from the date of randomization to the date of death or censored at the date of last follow up for the patients who are alive or lost to follow up, until 60 months To assess the effect of yoga on overall free survival in women breast cancer.